Lawrence Burton, PhD (died 1993)
.Lawrence Burton, a biologist and cancer researcher at the California Institute of Technology and St. Vincent's Hospital in New York, developed Immuno-Augmentive Therapy(IAT) in the 1960s. His research identified four blood protein components:

  • C3 complement - activates two tumor antibodies
  • TA1 and TA2 - tumor antibodies activated by C3 complement
  • DPF - protein that controls (blocks) the tumor antibodies

These four proteins need to be balanced for the body to defend itself from cancer growth. Burton's IAT consist of drawing blood from cancer patients, analyzing it and preparing specific amounts of these components back into the patients blood stream to balance them. His treatments are not a cure for cancer, but, like insulin for diabetes, a regulator that can control the cancer. It is virtually nontoxic.

"The survival rate of Dr. Burton's patients approximately doubled the maximum survival rate of conventionally treated patients. Had these findings pertained to chemotherapy drug instead of AIT, massive amounts of funding would have been allocated to investigate the drug."

­Definitive Guide to Cancer" page 886

IAT received a great amount of attention from the U.S. Congress when the Office of Technology Assessment's published it's 1990 report on unconventional cancer therapies.


Lawrence Burton passed away in 1993 from heart disease. Lawrence Burton's IAT is still available in the clinic he established in the 1970s in Freeport on Grand Bahama Island. One must be cautious of the flu season while visiting this tropical island while under the oppression of a cancer.


Story   |   Book List   |   About Prostheses   |   Home
How To Get Breast Cancer   |   Breast Cancer Treatments   |   Alternative Treatments